Delivery Order 75F40119D10025-75F40123F19006

Award Date 7/17/23
Potential Completion Date 9/14/25
Potential Value $334K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Concord, MA 01742, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The $99,447.00 contract is for an economic study titled "Recall Cost Case Studies Project" under the FDA's "Economic Studies of FDA Regulations" program. The contract is not set aside. ERG is a known environmental and health consulting firm that provides technical, research, and program management services...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order for $268,832.00 to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The order is for a "Survey of Domestic and Foreign Finished Pharmaceutical Manufacturing Practice, including Supply Chain for Management Practices for Drug Components, Containers, and Closures" and is issued under the existing Economic Studies of FDA Regulations...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The $496,714.00 contract is for an "Economics Characterization of Biologics Industry for ORA/OBPO" and is part of the larger "Economic Studies of FDA Regulations" Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. ERG, an environmental and health...
This is a delivery order under Contract No. 223-03-8500, awarded by the Food and Drug Administration (FDA), a civilian agency, to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The contract has a ceiling value of $79,974.00 and a firm fixed price pricing type. The task order is for drug safety work, with an ultimate completion date of August 12, 2011. ERG is a technical, research, and program management services provider that has expertise in areas such as chemical...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, to conduct TOBACCO PRODUCT MANUFACTURING PRACTICE RESEARCH. The $107,502.17 contract is a Labor Hours-based task order under the larger Economic Studies of FDA Regulations Indefinite Delivery/Indefinite Quantity (IDIQ) contract. ERG is a multidisciplinary consulting firm that provides technical,...
This is a federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The contract, valued at $130, is a Delivery Order for a "SURVEY OF FOOD INDUSTRY PRACTICES TASK" with a completion date of December 31, 2004. The contract type is Cost Plus Fixed Fee, and there is no set-aside designation. ERG is an environmental and health consulting firm that provides technical, research, and...
This is a federal contract award to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, by the Food and Drug Administration (FDA), a civilian agency. The contract is for an "INDUSTRY PROFILE OF FOOD SAMPLING FACILITIES" under the FDA's "ECONOMIC STUDIES OF FDA REGULATIONS" program. The contract has a ceiling value of $78,594.00 and was awarded on September 12, 2018, with a completion date of January 11, 2020. This award is a Delivery Order under the...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, to update the medical gas industry profile and estimate industry efforts to comply with current federal regulations. The $111,350.00 contract is part of the FDA's broader "Economic Studies of FDA Regulations" program and was not set aside for any socioeconomic business...
The Food and Drug Administration (FDA) has awarded a $509,877.20 Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for the FDA CDER DATA ANALYSIS SEARCH HOST (DASH) project. This contract is part of a larger parent contract called the "Economic Studies of FDA Regulations" Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle. The contract has a period of performance through September 4, 2025 and is a Time and Materials contract...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for a "THIRD PART ASSESSMENT OF COMBINATION PRODUCT REVIEW YEAR" with a potential value of $411,185.02. The contract was issued on June 8, 2018 with a completion date of December 31, 2020, and was not set aside for a specific business type. ERG is an environmental and health consulting firm...

This contract was awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for "ECONOMIC STUDIES OF FDA REGULATIONS". The contract is a Delivery Order under the "Economic Studies of FDA Regulations" parent IDIQ contract, with a ceiling value of $333,722.00 and a firm fixed price pricing type. The contract has no set-aside designation and is set to be completed by September 14, 2025. ERG is an environmental and health consulting firm that provides technical, research, and program management services to various federal agencies, including the EPA, CDC, and DOL. This contract leverages ERG's expertise in areas such as regulatory compliance and economic analysis to support the FDA's initiatives.

Generated 9/8/24, 12:10 AM